Dallas
2018 Annual Conference
The IHFDA 2018 conference turned out to be a huge success. Attendees were able to listen to some of the true experts in the field of health facility diversion present some of the most pressing issues currently being faced by our members. In addition, networking with other professionals in their field, along with a strong exhibitor field made for a formable conference for all. Positive comments were abundant as the IHFDA board also listened to how we can make a great conference even better in 2019 in Orlando.
Thanks to all who attended in 2018, hope to see all of you in Orlando in 2019.
John Burke
IHFDA President
Kim New
Executive Director
CE credit information is below.
Embassy Suites Hotel
2017 Conference Photos
Conference Speakers (A-Z)
Jeff Andert
Compliance Consultant
Kaiser Permanente
Enterprise Regional Compliance, Care Delivery and Pharmacy
“Pharmacy Investigations at Kaiser Permanente”
Harry Heinonen
Compliance Consultant
Kaiser Permanente
Enterprise Regional Compliance, Care Delivery and Pharmacy
“Pharmacy Investigations at Kaiser Permanente”
Karen Lettre
Diversion Specialist, Texas Children’s Hospital
“Developing a Diversion Prevention Program in a Children’s Health System”
Dennis Luken
Lauren Lollini
Jeannell M. Mansur, R.Ph, Pharm.D, FASHP, FSMSO, CJCP
Joint Commission Resources/Joint Commission International
“Medication Management and Diversion”
Jason Mehr, MPH, CIC
Healthcare Associated Infections Coordinator
Communicable Disease Service
New Jersey Department of Health
“Collaboration Between Public Health and Healthcare Facilities”
Ben Mink
“A Close Encounter: How to Effectively Reduce Controlled Substance Liability- Pre, Mid, & Post DEA Regulatory Action”
Philip A. Mullenix
Aurora Pop-Vicas, MD, MPH
Assistant Professor, Infectious Diseases, Associate Hospital Epidemiologist, University of Wisconsin School of Medicine
“Tampering and Substitution: A Case Study from the University of Wisconsin”
Shabbir Imber Safdar
Partnership of Safe Medicines
“Protecting Patients from Harm Associated with Counterfeit Medications”
Shawn Parekh, PharmD, MHA, FACHE
National, Chief Pharmacy Officer
Prospect Medical Holdings, Inc
“A Case Study on Diversion, A Culture of Excellence”
Michele Sheaffer
Abington Memorial Hospital
“A Case Study on Diversion, A Culture of Excellence”
Greg Raymond DNP, MBA, RN, NEA-BC
“Using Huddles to Improve Diversion Investigations”
Lisa Robin, MLA
“Role of Medical Boards in Drug Diversion Cases”
CE Credit Information
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Nurses / Pharmacists
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Internal Health Facility Diversion Association. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 14.25 contact hours for nurses and number of knowledge/application/practice-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Exhibitors (A-Z)
